Tag Archives: ErVimmune

BIOTECH

ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate

Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman....

Read more